Sign in →

Test Code CMVP Cytomegalovirus (CMV) DNA PCR, quantitative

Additional Codes

EPIC Ordering code LAB2087
NBS code LBC04235
Service code 1033105

 

Specimen Requirements

Submit the following    
Preferred Acceptable  
EDTA tube BAL/CSF/Urine (white sterile contatiner) UTM (swab)

 

Preferred:
Specimen Type:
Whole Blood or Bone Marrow Aspirate
Container/Tube: Lavender Top (EDTA)
Specimen Volume: 3.0 mL (at least 1.0 mL for bone marrow aspirate)

 

Specimen Type: Plasma
Container/Tube: Sterile Container
Specimen Volume: 2.0 mL

 

Acceptable: (only qualitative results will be available)

Specimen Type: Bronchoalveolar Lavage (BAL)

Container/Tube: Sterile Plain Container

Specimen Volume: Entire collection

 

Specimen Type: Cerebrospinal Fluid (CSF)

Container/Tube: Sterile Plain Container

Specimen Volume: Entire collection

 

Specimen Type: Swab Sources: Nasal, throat, rectal (others please specify)

Container/Tube: Universal Transport Media (dry swab in plain container is acceptable too)

Specimen Volume: Entire collection

 

Specimen Type: Tissue Biopsy

Container/Tube: Sterile Container with 1.0 - 2.0 mL of sterile saline

Specimen Volume: Entire collection

 

Specimen Type: Urine

Container/Tube: Sterile Plain Container

Specimen Volume: 2.0 mL

Specimen Stability and Condition

Whole Blood (EDTA) 72 hours, ambient/refrigerated
Plasma 7 days, refrigerated
Cerebrospinal Fluid (CSF) 3 days, refrigerated
Eye aqueous or vitreous 3 days, refrigerated
Unsuitable condition (reject) Whole Blood: Frozen or hemolysis
Unsuitable condition (reject) Bone Marrow Aspirate: Frozen or hemolysis

Methodology

Real-time Polymerase Chain Reaction, Quantitative

Days and Times Performed

TAT 7 days

Reference Interval

Sample Matrix Linear Range Limit of Detection (LoD)
EDTA plasma

180 IU/mL to 15,000,000 IU/mL

90 IU/mL

Testing Laboratory

National University Hospital

Molecular Microbiology Laboratory (MML), Microbiology division, 67724384

Useful For

For early detection of cytomegalovirus (CMV) infection and to monitor CMV disease and response to viral therapy, in immunocompromised individuals after organ transplantation or with leukemia.

Update

Last updated 4/08/2026

LOINC Code Information

34720-3